AN-018

N/A

Report date: 2025/10/21 14:45:47
NME

Base Information

Drug NameAN-018
Drug Alias NameAN-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-3, mitochondrial modulators
TargetsNAD-dependent protein deacetylase sirtuin-3, mitochondrial
Therapy Area/IndicationsNeurocognitive DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAccuitis Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAccuitis Inc
Inactive CompaniesN/A
Active IndicationsNeurocognitive DisordersParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A